ROTAVAC® India’s first indigenously developed Rotavirus Vaccine. The vaccine will be sold to global public markets, Governments worldwide including UN procurement agencies at a price of US $ 1. Bharat Biotech hopes its new vaccine will help prevent part of the ~ 500,000 child deaths each year caused due to rotavirus diarrhea and improve access to better, affordable rotavirus vaccines.
Rotavirus is the top cause of deadly diarrhea in developing countries. ROTAVAC® was developed by a cross-sector partnership led by the Government of India.
Publicly available: yes
Countries where available: India
Price range (USD): 1 to 20 USD
If you are aware of any updates to the ROTAVAC project please complete the form or send an email to [email protected]
Need help finding solutions that respond to your unique development challenges? Apply through our Project Accelerator service or Contact us directly for needs-based project consulting.